Levofloxacin Hydrate

Specifications

138199-71-0CAS Number

604-067-2EC Number

bis((2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid);hydrateIUPAC Name

C36H42F2N6O9Chemical Formula

740.7 g/molMolecular Weight

Levofloxacin hydrate; DTXSID60160533; RefChem:1088440; DTXCID2083024; (3S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid hemihydrate; 138199-71-0; Dynaquin; MFCD07772024; Levofloxacin (hydrate); (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrate(2:1); 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (3S)-; Levaquin (TN); 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-hydrate (2:1), (S)-; Levofloxacin [USAN]; (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrate; UNII-6GNT3Y5LMF; RWJ 25213; 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (3S)-; 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (S)-; Dynaquin; Leeflox; Levofloxacin; Levofloxacin hydrate; Levofloxacin (USP); Quixin (TN); Iquix (TN); LevofloxacinHemihydrate; Levofloxacin hemihydrate CRS; LEVOFLOXACIN [VANDF]; LEVOFLOXACIN [MART.]; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate (2:1); Levofloxacin hydrate (JP18); LEVOFLOXACIN [USP-RS]; LEVOFLOXACIN HEMIHIDRATED; orb1308581; SCHEMBL1650602; CHEMBL5315124; C36H42F2N6O9; LEVOFLOXACIN [ORANGE BOOK]; LEVOFLOXACIN HYDRATE [JAN]; (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid Hemihydrate; LEVOFLOXACIN [USP MONOGRAPH]; EBC-13487; AKOS015896149; FL24883; KS-1077; Levofloxacin [USAN:USP:INN:BAN:JAN]; LEVOFLOXACIN HEMIHYDRATE [WHO-DD]; (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hemihydrate; DA-54880; SY010305; L1785; T1451; D00588; LEVOFLOXACIN HEMIHYDRATE [EP MONOGRAPH]; OFLOXACIN S-(-)-FORM HEMIHYDRATE [MI]; EN300-20644132; F861807; Q47495791; Levofloxacin, United States Pharmacopeia (USP) Reference Standard; Levofloxacin Hemihydrate, Pharmaceutical Secondary Standard; Certified Reference Material; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihy drate; (3S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid--water (2/1); bis((2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0,5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid) hydrate; Levofloxacin hemihydratSynonyms